As Tylenol Lawsuits Move Forward, FDA Calls on Doctors to Stop Prescribing High-Dose Prescription Ac

The Firm is evaluating Tylenol lawsuits on behalf of individuals who allegedly suffered acetaminophen-induced liver damage due to their use of over-the-counter Tylenol products. New York, New York (PRWEB) April 29, 2014 As dozens of Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to move forward in federal court, Bernstein Liebhard LLP notes that federal health regulators are once again warning doctors not to prescribe medications that contain more than 325 milligrams of acetaminophen, due to the risk of liver damage posed by such products. In a statement posted on its w
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations